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Purpose:Hypercholesterolemia, a risk factor foratherosclerosis (ATH)has
been suggested tohave a role in thedevelopmentof osteoarthritis (OA). To
test thishypothesis, theeffectof increasingcholesterol levels anddifferent
cholesterol-lowering treatments on the development of OA was investi-
gated in a mouse model resembling human lipoprotein metabolism.
Methods: Female ApolipoproteinE*3Leiden.human Cholesteryl Ester
Transfer Protein (APOE*3LeidenCETP) transgenic mice (10-16 wks,
n¼12/group) received a western type diet (WTD). This diet was sup-
plemented with 0.1% (w/w) cholesterol (LC), 0.3% (w/w) cholesterol
alone (HC) (n¼12) or HC with 3 mg/kg/day of the HMG-CoA reductase
inhibitor atorvastatin (HC atorvastatin) or 0.3 mg/kg/day of the
cholesterol absorption inhibitor ezetimibe (HC ezetimibe). One group
remained on chow (control). After 39 weeks of intervention, mice were
sacriﬁced and OA grades in the knee and atherosclerosis size and
composition in the aortic origin were assessed. Plasma cholesterol
levels were measured throughout the study.
Results:Mice receiving LC and HC had signiﬁcantly more OA features at
the medial side of the knee joint compared to control mice. OA features
were signiﬁcantly suppressed by atorvastatin but not by ezetimibe. No
effects of increased intake of cholesterol were seen on the lateral side or
the patella. HC groups developed signiﬁcantly more atherosclerosis
which was suppressed to a similar extent by atorvastatin and ezetimibe
(48% and 55% respectively). A signiﬁcant mild association between the
development of OA on the medial side and cholesterol exposure or
atherosclerosis development was found (both R¼0.4, p<0.05).
Conclusions: Dietary cholesterol and consequently increased plasma
cholesterol levels play a role in the development of OA. The moderate
correlation betweenOA and cholesterol exposure in thesemice suggests
that atherosclerosis and osteoarthritis are associated through common
underlying mechanisms, but that processes independent of cholesterol
exposure contribute to the development of OA features as well. This is
further substantiated by the difference in effect of atorvastatin and
ezetimibe. Although both drugs reduced cholesterol levels to the same
extent, only atorvastatin signiﬁcantly diminished OA severity, ruling out
cholesterol exposure as single factor in OA development.Fig. 1. A) Genes differentially expressed in the VLDmodel and human OA (Aigner, 2007;
Karlsson, 2010), B) Venn diagram illustrating load-induced differential expression (100%
vs. 0%BW) at 6 and 20 wks; and select genes with increased ([) and decreased (Y)
expression. C) Fold changes of genes differentially expressed in the VLDmodel at 20wks
(x-axis) in common with those expressed in human OA (y-axis) illustrating that the
majority of common genes trended in the same direction (shaded quadrants).105
GLOBAL ANALYSIS OF CHONDROCYTE GENE EXPRESSION IN LOAD-
INDUCED CARTILAGE DEGENERATION IN THE RAT
M.L. Roemhildt, A.E. Gauthier. Univ. of Vermont, Burlington, VT, USA
Purpose: This study 1) investigated time-dependent changes in chon-
drocyte gene expression in response to increased chronic in vivo loading
of the rat tibiofemoral joint to identify molecular pathways regulating
response to loading and early joint degeneration; and 2) compared the
genetic response of our animal model to that in human OA.
Methods: NIH guidelines for the use of animals were observed. Twenty
mature male Sprague-Dawley rats were randomized into 4 groups: 0%-
6wk, 0%-20wk, 100%-6wk, and 100%-20wk. A varus loading device
(VLD) surgically attached to the hind limb of the rat applied an overload
of 0% or 100% body weight to the medial compartment of the knee 24
hr/day for 6 or 20 weeks. Loads were in addition to normally occurring
joint forces. Microarray analysis was performed (Affymetrix Rat
GeneArray 1.0 ST representing 27,342 genes) on individual RNA samples
extracted from articular cartilage of medial femoral condyles. Total RNA
was ampliﬁed, hybridized, and scanned. After bioinformatics processing
of raw data, linear models were evaluated using ANOVA-derived
expression statistics. Candidate genes for pathway analysis were
selected as those exhibiting a p-value  .05 and jfold-changej  1.2
between groups. Immunohistochemistry (IHC) validated select genes
dysregulated in our analysis. DAVID Bioinformatics Resources identiﬁed
sets of genes and their associated biological pathways that were over-
represented with increased load. The genetic response of the rat VLD
model was compared to that of human OA by comparing differentially
expressed transcripts to orthologs in 2 reported human studies.
Results: Increased loading resulted in differential expression of 634
transcripts at 6 weeks and 898 transcripts at 20 weeks (Fig1A). DAVID
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associated with inﬂammatory/defense response; response to extracel-
lular stimulus or nutrient levels; and apoptosis. Genes with lower
expression at 6 weeks were related to ion/metal binding or mitochon-
dria and ribosome. At 20 weeks, genes related to extracellular matrix
region/signaling/organization/structure; acute inﬂammatory/defense
response; and mineralization were expressed at higher levels, while
genes related to the structure and function of the mitochondria, ribo-
some, and glutathione proteins were expressed at lower levels. IHC
veriﬁed increased CCL2, CHI3L1, and MMP13 with increased load in the
articular cartilage. Comparisons between the rat VLD and human OA
gene proﬁles revealed that in both 1/2 of the observed transcripts were
up-regulated (Fig1A) with w19% of differentially expressed transcripts
in common, of these common transcripts 73-84% trended in the same
direction (Fig1C).
Conclusions: Findings build on preliminary analysis of gene expres-
sion with increased chronic load by validating dysregulated genes on
a protein level, identifying pathways regulating response, and
comparing results to human OA. We observed differential expression
of genes previously reported with OA as well as novel targets.
Pathway analysis emphasized processes similar to those reported in
human OA, most notably: apoptosis, differentiation, and the produc-
tion and regulation of chemokines, cytokines, and enzymes; including
the up-regulation of genes involved in inﬂammation and extracellular
matrix and the down-regulation of genes involved in oxidative
damage defense.
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INDUCIBLE CHONDROCYTE-SPECIFIC OVEREXPRESSION OF BMP2 IN
YOUNG MICE RESULTS IN SEVERE AGGRAVATION OF OSTEOPHYTE
FORMATION IN EXPERIMENTAL OA WITHOUT ALTERING
CARTILAGE DAMAGE
E.N. Blaney Davidson, E.L. Vitters, M.B. Bennink, A. van F. de Loo, B. van
W. den Berg, M. van P. der Kraan. Radboud Univ. Nijmegen Med. Ctr.,
Nijmegen, The Netherlands
Purpose: In murine models of osteoarthritis (OA) chondrocytes
surrounding lesions express elevated levels of BMP2, a growth factor
known for its ECM inducing qualities and capability to induce new
cartilage and bone. The functional consequence of elevated BMP2 levels
in articular chondrocytes is unclear. Thereforewe investigated the effect
of chondrocyte-speciﬁc BMP2 overexpression on articular cartilage and
novel cartilage/bone formation (osteophytes) during OA. We made
a collagen type II dependent, doxycycline-inducible BMP2 transgenic
mouse. The consequence of elevated chondrocyte-speciﬁc BMP2 on
experimental OAwas investigated in the destabilization of themeniscus
(DMM) model.
Methods: We cloned a lentivirus with BMP2 controlled by a minCMV
promoter coupled to a tet responsive element (Lv-TRE-BMP2).We
crossed a Col2-cre mouse with a ﬂoxed rtTA mouse and transfected
homozygote embryo's with Lv-TRE-BMP2 to gain a transgenic mouse
expressing collagen type 2 dependent BMP2 solely in chondrocytes only
upon doxycycline (dox) exposure (Col2-rtTA-TRE-BMP2). BMP2 inte-
gration sites were localized andwe tested inducibility, functionality and
tissue-speciﬁcity of BMP2 expression. Experimental OA was induced
(DMM model) in Col2-rtTA-TRE-BMP2 mice with or without dox
exposure in food starting oneweek before DMM, lasting until the end of
the experiment (8 weeks after DMM). We isolated knee joints for
histology. Left knee joints served as non-OA controls.
Results: DMM treated mice without dox showed osteophyte formation
predominantly on the medial side of the joint originating from the
periost near the femoral-tibial joint and extruding from the medial
meniscus. Upon dox exposure, osteophyte formation aggravated
severely resulting in outsized osteophytes, enthesophytes on the
enthesis of the medial collateral ligament, new bone formation within
the collateral ligament near the extruded meniscus and osteophyte
formation originating from the femoral growth plate, predominantly
but not exclusively on the medial side of the joint. There were no
signiﬁcant differences in non-DMM joints when comparing dox versus
non-treated transgenics. In contrast, dox treatment resulted in very
large osteophytes in the thoracic or cervical area of the spine. Strikingly,
despite the apparent changes in the joint morphology due to the large
osteophytes there was no detectible difference, with regard to struc-
tural damage and Safranin O staining intensity, in cartilage damage
when comparing DMM with or without dox.Conclusions: Elevated BMP2 levels in chondrocytes did not induce
structural changes in articular cartilage of young mice. Moreover, like in
our prior experiments with Ad-BMP2, unchallenged dox treated joints
did not show any structural alterations in cartilage. In DMM mice,
additional BMP2 expression greatly enhanced de novo cartilage
formation, eventually turning into bone (osteophytes). which was not
seen in non-DMM animals. We postulate that newly-induced chon-
drocytes produce high BMP2 levels in dox-treated transgenics, that
boost outgrowth of these structures. In spine however, osteophytes
developed in dox-treated transgenics without additional triggers. This
could rely on chondrocyte precursor subpopulation that is stimulated to
undergo chondrogenesis under control of BMP2 alone.
Our data show that chondrocyte-speciﬁc elevation of BMP2 levels does
not alter the course of cartilage damage in an OA model in young mice
but results in severe aggravation of osteophyte formation.
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MEDIAL MENISCUS TRANSECTION IN THE RAT RESULTS IN MODIFIED
GROUND REACTION FORCES AND SUBSEQUENT DEVELOPMENT OF
KNEE OA
H.E. Kloefkorn, B.L. Jacobs, A.M. Loye, K.D. Allen. Univ. of Florida,
Gainesville, FL, USA
Purpose: Traumatic knee injury signiﬁcantly increases a person's risk
for developing knee osteoarthritis (OA). Moreover, histological features
of OA can be replicated by surgically-simulating traumatic knee injury
in preclinical animal models. For example, radial transection of the
medial knee meniscus in the rat results in the formation of cartilage
lesions and osteophytes. The development of OA-related pain and
disability in preclinical models is less well understood. The purpose of
this study is to describe gait abnormalities subsequent to radial medial
meniscus transection (MMT) in the rat.
Methods: The right medial collateral ligament (MCL) was transected in
64 male Lewis rats (250 g). In 32 of these rats, the medial meniscus was
exposed and transected (MMT surgery); the remaining 32 rats served as
sham surgery controls (MCL transection alone). At 1, 2, 4, and 6 weeks
following surgery, 8 rats per surgical group were placed in a gait arena
with 7 force plates embedded in the ﬂoor (Kistler 2 kN 3-component
force link). Gait testing was also performed on 8 weight-matched male
Lewis rats (Naïve). When a rat contacted a force plate, a video camera
was triggered, with videos used to calculate the animal's velocity and
ensure the rat's foot was in complete contact with the force plate.
Ground reaction forces were generalized as peak vertical force, vertical
impulse (area under the force-time curve), peak braking force, braking
impulse, peak propulsive force, and propulsive impulse. Data were
compared between groups using generalized regression models that
accounted for a linear dependence upon trial velocity. Following gait
testing, animals were euthanized and joint tissues assessed using the
OARSI histopathology scheme for the rat.
Results: Peak vertical force and vertical impulse decreased following
MMT surgery. Both peak vertical force and vertical impulse were lower
in the operated limb of MMT rats relative to the contralateral limb
(p¼0.049, p¼0.042, Figure 1, Left Column). Moreover, peak vertical
force and vertical impulse were lower in the operated limb of MMT rats
relative to the operated limb of rats receiving MCL transection alone
(p<0.001, p¼0.008, Figure 1, Right Column). Braking and propulsive
ground reaction forces were also altered following MMT surgery. Peak
propulsive force and propulsive impulse were reduced by 11.9% and
16.5%, respectively, in rats with MMT surgery relative to rats receiving
MCL transection alone (p¼0.010, p¼0.003). However, no differences
were observed between propulsive forces on the operated and
contralateral limb in either surgical group. Relative to the contralateral
limb, peak braking force and braking impulse were reduced by 29.9%
and 40.6%, respectively, in both the operated limb of rats receiving the
MMT surgery and rats receiving MCL transection alone (p<0.001,
p<0.001), indicating changes in braking force were associating with
MCL transection. Joint histology revealed progressive cartilage damage
and the formation of osteophytes along the margins of the knee in the
MMT surgical group (Figure 2). Cartilage lesions increased in both size
and depth out to 6 weeks, with signiﬁcant osteophytes formation
observed at 4 and 6 weeks. No evidence of OAwas observed in rats with
MCL transection alone group.
Conclusions: While pain and disability are commonly evaluated in
clinical settings, disease symptoms are more challenging to assess in
preclinical models. These data demonstrate dynamic gait abnormalities
